Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06708728
NCT06708728Not yet recruitingNot Applicable

Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease

Sohag University1 site in 1 country60 target enrollmentStarted: December 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
intensive care unit admission of the patients due to progression of the disease complications.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.

And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults aged 18 years and older.
  • •Patients diagnosed with acquired hemolytic anemia.
  • •Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
  • •Patients (or their legal representatives) must provide informed

Exclusion Criteria

  • •Patients with underlying neoplastic diseases.
  • •Patients with hereditary hemolytic anemia.
  • •Patients or their representatives who do not consent to participate in the study.

Outcomes

Primary Outcomes

intensive care unit admission of the patients due to progression of the disease complications.

Time Frame: through study completion, an average of 6 months

Primary outcome will be ICU admission due to progression of the disease complications.

Secondary Outcomes

  • mortality within duration of hospital admission(through study completion, an average of 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Elsayed Mahmoud

resident doctor

Sohag University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Etiology, Clinical Picture, Complications and Outcomes of Necrotizing Pancreatitis in Children.Pancreatitis, Acute NecrotizingChildrenPancreatitis
NCT06700330Moscow Regional Research and Clinical Institute (MONIKI)102
Completed
Not Applicable
Descriptive and Correlational Study of Peritonitis in Haiti.Peritonitis
NCT04182217Universite d'Etat d'Haiti91
Completed
Not Applicable
Causes and Outcomes of Community Acquired PneumoniaCommunity Acquired Pneumonia
NCT01336036Oxford University Clinical Research Unit, Vietnam300
Completed
Not Applicable
Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in EcuadorMyeloproliferative NeoplasmMyeloproliferative SyndromeMyeloproliferative Neoplasm, UnclassifiableMyeloproliferative DisordersMyeloproliferative Disease, Not Classified
NCT05825326Sociedad de Lucha Contra el Cáncer del Ecuador40
Completed
Not Applicable
Infective Keratitis in Minia GovernateInfective Keratitis
NCT04894630Minia University150
Study of Acquired Hemolytic Anemia in... | Clinical Trial